BIOMAT Database Logo BIOMAT Database Logo

Detection of induced resistance to cytosine-arabinoside with a short-term test. 1980

M Volm, and E Maas, and J Mattern

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Volm, and E Maas, and J Mattern
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
February 1981, Clinical science (London, England : 1979),
M Volm, and E Maas, and J Mattern
Cytosine arabinoside-induced vasculitis.
March 1998, Mayo Clinic proceedings,
M Volm, and E Maas, and J Mattern
Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
November 1977, Archiv fur Gynakologie,
M Volm, and E Maas, and J Mattern
Thymineless death induced by cytosine arabinoside.
October 1968, Biochimica et biophysica acta,
M Volm, and E Maas, and J Mattern
Pyrexia with cytosine arabinoside.
October 1972, British medical journal,
M Volm, and E Maas, and J Mattern
Resistance to cytosine arabinoside in cells transfected with activated Ha-ras oncogene.
January 1995, Anticancer research,
M Volm, and E Maas, and J Mattern
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.
May 1974, British journal of haematology,
M Volm, and E Maas, and J Mattern
A new pattern of cytosine-arabinoside-induced lung toxicity.
December 2009, British journal of haematology,
M Volm, and E Maas, and J Mattern
Cytosine arabinoside induced liver damage: histopathologic demonstration.
January 1983, Medical and pediatric oncology,
M Volm, and E Maas, and J Mattern
Prophylactic treatment for cytosine arabinoside-induced keratoconjunctivitis.
June 2011, International ophthalmology,
Copied contents to your clipboard!